Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

33.53
Delayed Data
As of May 27
 +0.55 / +1.67%
Today’s Change
27.62
Today|||52-Week Range
51.42
-21.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues214.2M221.1M282.1M225.5M
 
 
 
 
 
Cost of Goods Sold109.1M107.2M140.0M105.8M
 
 
 
 
 
Depreciation And Amortization20.3M18.0M20.0M15.7M
 
 
 
 
 
 
Operating ExpensesGross Income84.9M95.9M122.1M104.0M
 
 
 
 
 
General Expenses65.3M62.5M76.8M111.4M
 
 
 
 
 
Research And Development17.0M18.6M20.0M19.0M
 
 
 
 
 
Total Operating Expenses194.6M187.7M236.8M232.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income19.5M33.4M45.3M-7.4M
 
 
 
 
 
Extraordinary Credit--0.00300.0K0.00
 
 
Extraordinary Charge-18.4M-9.9M-23.8M-2.7M
 
 
 
 
 
Interest Expense On Debt7.0M8.2M8.2M8.3M
 
 
 
 
 
Other Expenses961.0K45.7M-574.0K596.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.5M61.3M13.3M-17.5M
 
 
 
 
 
Income Taxes-2.7M-25.6M-1.9M-7.1M
 
 
 
 
 
Net Income-1.9M35.8M11.4M-10.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.3M69.8M70.4M70.7M
 
 
 
 
 
Shares To Calculate EPS Diluted69.3M72.8M72.0M70.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03$0.49$0.16-$0.15
 
 
 
 
 
EPS Diluted-$0.03$0.49$0.16-$0.15